Table 2: Patient characteristics and treatments received before initiation of ketogenic diet.
Patient | Age | Sex | Diagnosis | EEG | Previously epilepsy history | Duration of SE before KD (days) | Number of AEDs before SE | Steroid or ACTH before KD | IVIG before KD |
1 | 3 | Female | LGS | Gen. SE | Yes | 11 | LEV, VPA, PHT, CZP, CLB, PB, TPN, MDZ |
Yes | No |
2 | 2 | Female | Cerebral palsy, refractory epilepsy | Focal SE | Yes | 20 | 6 LEV, VPA, PHT, CBZ, CLB, PB, TPN, MDZ |
No | Yes |
3 | 3 | Female | LGS | Gen. SE | Yes | 15 | 6 LEV, VPA, PHT, TPM, PB, TPN |
No | Yes |
4 | 9 | Female | Epileptic encephalopathy (of unknown cause, unclassifiable) | Jen. SE | Yes | 13 | 8 LEV, VPA, PHT, CLB, PB, TPN, MDZ, PPF |
Yes | Yes |
5 | 5 | Male | HSV encephalitis | Focal SE | No | 12 | 5 LEV, VPA, PHT, CBZ, TPN |
No | No |
6 | 1 | Male | Epileptic encephalopathy (WOXX mutation) | Jen. SE | Yes | 8 | 4 LEV, PHT, PB, TPN |
No | No |
AED: Antiepileptic Drug; CBZ: Carbamazepine; CLB: Clobazam; CZP: Clonazepam; EEG: Electroencephalography; Focal SE: Focal Status Epilepticus; Gen. SE: Generalized Status Epilepticus; HSV: Herpes Simplex Virus; IVIG: Intravenous Immunoglobulin; KD: Ketogenic Diet; LGS: Lennox-Gastaut Syndrome; LEV: Levetiracetam; MDZ: Midazolam; PHT: Phenytoin; PB: Phenobarbital; TPN: Thiopental; TPM: Topiramate; VPA: Valproic Acid.